SHIFT Newsroom · GLOBAL
Trial record: GLP-1 treatment during lorlatinib therapy
Registry status checked on 3 October 2026: not yet recruiting.
ClinicalTrials.gov lists NCT07782359, concerning GLP-1 treatment during lorlatinib therapy, as not yet recruiting. The record was first posted on 2026-08-24 and last updated on 2026-08-24; SHIFT checked it on 3 October 2026. It should not be described as already enrolling or treating participants.
The registration describes a research question and protocol, not proof that the intervention is effective or suitable for an individual.
No results tables were posted in this registry record when checked. That does not establish that no results have been published elsewhere. A registry entry is not a UK marketing authorisation or confirmation of NHS access.
SHIFT’s take
Keep the trial status, published results and UK treatment access separate. Do not change treatment on the basis of a registration.